Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Emergent Health Corp. (OTC: EMGE).

Full DD Report for EMGE

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-07N/A0.042N/AN/A39
2018-12-06N/A0.042N/AN/A0
2018-12-050.0420.0420.0420.0421,400
2018-12-040.0420.0420.0420.0421,400
2018-12-03N/A0.042N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-275,5005,71596.2380Short
2018-10-19110110100.0000Short
2018-09-202,5002,70092.5926Short
2018-08-292001,47013.6054Cover
2018-08-2133735993.8719Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EMGE.


About Emergent Health Corp. (OTC: EMGE)

Logo for Emergent Health Corp. (OTC: EMGE)

Emergent Health Corp. engages in the discovery, development and marketing of products designed to better mankind. Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third party label exemptions. Emergent is focusing current efforts on marketing licensed patent pending natural stem cell mobilizing agents capable of enhancing each individual s ability to mobilize their own adult stem cells from their bone marrow. Emergent is also licensed under a patent pending application to market a dual acting all natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and Professional markets. Research and Development is exploring other areas such as Secretogues that can naturally enhance a person s own Growth Hormone production and similar all natural bioactive formulations to enhance human performance safely, ethically, legally and utilizing known body mechanisms without the use of drugs. Emergent does not claim any of its products diagnose, treat, cure or prevent any disease. Emergent was founded in and is now headquartered in King of Prussia, PA.

 

Contact Information

 

 

Current Management

  • Chris Swenson / CEO, President
    • Mr. Swenson brings over years of financial experience to the Company. His areas of concentration include financial analysis, strategic planning, business development and budgeting. Since Mr. Swenson has served as the Chief Financial Officer of Neaclear , Inc. a company located at West Adams Street, Suite , Chicago, IL engaged in marketing and the distribution of Skin Care. From through he served as the Chief Financial Officer of CENX, Inc., located in Ottowa, ON CANADA whose principal business was Software Services From through he served as the VP of Finance for Inteliquent Corp, located in Chicago, Il and engaged in Telecom Services.
  • John V. Cappello, D.O, M.B.A / Chief Scientist
  • Kim Halvorson / IR
    • Ms. Halvorson is seasoned Business Development and Marketing professional that thrives in new and innovative environments. Over her year healthcare career, she has contributed to all spectrums of the business continuum. She started in medical practice management software systems and then moved to holding strategic roles in large corporate structures such as Dell Computer Corporation, and other successful healthcare startups like SCI Solutions. complex hospital scheduling After leaving Dell she went on to be a founding partner at Triage VC, were she worked with several startup ventures leveraging her vast industry connections. Her expertise helped to accelerate early stage startups in the areas of investment banking, marketing and business development. . While at Dell she reported to the Director of Dell Healthcare with revenues in excess of billion dollars annually. Responsibilities included all commercial EHealth strategies and corporate partnerships within the Healthcare Division. Kim also worked with Dell Direct Invest with regard to the Healthcare Division s strategic investments.
  • M. Scott Maguire / Chairman
  • Chris Swenson / Director
    • Mr. Swenson brings over years of financial experience to the Company. His areas of concentration include financial analysis, strategic planning, business development and budgeting. Since Mr. Swenson has served as the Chief Financial Officer of Neaclear , Inc. a company located at West Adams Street, Suite , Chicago, IL engaged in marketing and the distribution of Skin Care. From through he served as the Chief Financial Officer of CENX, Inc., located in Ottowa, ON CANADA whose principal business was Software Services From through he served as the VP of Finance for Inteliquent Corp, located in Chicago, Il and engaged in Telecom Services.

Current Share Structure

  • Market Cap: $302,480 - 03/14/2018
  • Authorized: 100,000,000 - 10/14/2014
  • Issue and Outstanding: 39,800,000 - 08/28/2014
  • Float: 4,083,089 - 11/12/2014

 



Daily Technical Chart for (OTC: EMGE)

Daily Technical Chart for (OTC: EMGE)


Stay tuned for daily updates and more on (OTC: EMGE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: EMGE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EMGE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of EMGE and does not buy, sell, or trade any shares of EMGE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/